Doxymit 10mg/10mg/2.5mg Tablet
strip of 10.0 tablets.Prescription required
About this product:
| Salt Composition: | Doxylamine (10mg) + Vitamin B6 (Pyridoxine) (mg) + Folic Acid (2.5mg) |
| Manufacturer: | Mits Healthcare Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Doxymit 10mg/10mg/2.5mg Tablet is a combination medicine used in the treatment of nausea or vomiting during pregnancy. Doxymit 10mg/10mg/2.5mg Tablet is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Doxymit 10mg/10mg/2.5mg Tablet is a combination of three medicines: doxylamine, vitamin B6 (pyridoxine) and folic acid, which treats nausea and vomiting associated with pregnancy.
What are the instructions for storage and disposal of Doxymit 10mg/10mg/2.5mg Tablet?
Store Doxymit 10mg/10mg/2.5mg Tablet in its original container, tightly closed, at the temperature and humidity specified on the packaging or label. Dispose of any unused medication properly, ensuring it is not accessible to pets, children, or other individuals.
Can I take a higher than the recommended dose of this medicine?
No, taking a higher dose of Doxymit 10mg/10mg/2.5mg Tablet than recommended can increase the risk of severe side effects. If you experience persistent or severe nausea or vomiting despite taking the recommended dose, consult your doctor for re-evaluation and guidance.
Can the use of Doxymit 10mg/10mg/2.5mg Tablet cause drowsiness or sleepiness?
Yes, drowsiness is a common side effect of Doxymit 10mg/10mg/2.5mg Tablet. Avoid driving, operating heavy machinery, or engaging in activities that require full attention. Additionally, avoid consuming alcohol or taking other medications that can depress the central nervous system, such as cough and cold medicines, certain pain medications, and sleep aids, while taking Doxymit 10mg/10mg/2.5mg Tablet. Severe drowsiness can increase the risk of falls or accidents.
Can the use of Doxymit 10mg/10mg/2.5mg Tablet cause dry mouth?
Yes, Doxymit 10mg/10mg/2.5mg Tablet may cause dry mouth. To alleviate this side effect, drink plenty of water throughout the day and keep a glass of water by your bedside at night. Avoid consuming acidic, spicy, or salty foods.
Can a pregnant woman take Doxymit 10mg/10mg/2.5mg Tablet?
Yes, Doxymit 10mg/10mg/2.5mg Tablet is generally considered safe for pregnant women. In fact, it is often prescribed to treat nausea and vomiting in pregnant women who have not responded to dietary changes or other non-medicine treatments.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Doxymit 10mg/10mg/2.5mg Tablet is to be taken with food.
- Doxymit 10mg/10mg/2.5mg Tablet helps treat nausea and vomiting in pregnant women whose symptoms did not improved using diet and lifestyle changes.
- Take it on an empty stomach with a glass of water.
- It may cause dizziness. Do not drive or do anything requiring concentration until you know how it affects you.
- Do not take it with other sedating medications such as cough and cold medications as the combination could worsen dizziness leading to falls or other accidents
Alcohol
Caution is advised when consuming alcohol with Doxymit 10mg/10mg/2.5mg Tablet. Please consult your doctor.
Breastfeed
Doxymit 10mg/10mg/2.5mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Larger doses or prolonged use of Doxymit 10mg/10mg/2.5mg Tablet may cause sleepiness and other effects in the baby
Pregnancy
Doxymit 10mg/10mg/2.5mg Tablet is safe to use during pregnancy. Most studies have shown low or no risk to the developing baby.
